CIK 0001347242
LIPO LIPELLA PHARMACEUTICALS INC.
Insider trading from SEC Form 4. Last filing Apr 7, 2025. Close $0.00 on Oct 12, 2026, +200% from the 52-week low and -100% from the high.
In brief
LIPELLA PHARMACEUTICALS INC. (LIPO) has 18 SEC Form 4 filings on file from 8 insiders, the latest filed on Apr 7, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at LIPO. The newest: Jonathan H Kaufman (See remarks below.) bought $7,590 of stock on May 14, 2024, filed May 15, 2024, scored 20 (weak). The largest of the 2 shown: Jonathan H Kaufman (See remarks below.) bought $45k on Mar 18, 2024, scored 24 (weak).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at LIPELLA PHARMACEUTICALS INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Jonathan H Kaufman See remarks below. buy | $7,590 10,000 shares | +1% | - | |
| 24Weak | Jonathan H Kaufman See remarks below. buy | $45k 55,000 shares | +7% | - |
Transactions
Every row filed, 30 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | Jonathan H Kaufman See remarks below. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | -536,959 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Apr 3, 2025 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | -125,833 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Apr 3, 2025 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | -28,924 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Apr 3, 2025 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | -4,060 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Mar 13, 2025 | Jonathan H Kaufman See remarks below. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | +10,326 | $0.00 | $0 | 536,959 | Mar 17, 2025 |
| Mar 13, 2025 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | +4,060 | $0.00 | $0 | 4,060 | Mar 17, 2025 |
| Mar 10, 2025 | Jonathan H Kaufman See remarks below. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below)( | +84,700 | $0.00 | $0 | 526,633 | Mar 11, 2025 |
| Mar 10, 2025 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | +28,924 | $0.00 | $0 | 28,924 | Mar 11, 2025 |
| Feb 28, 2025 | Jonathan H Kaufman See remarks below. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | +441,933 | $0.00 | $0 | 441,933 | Mar 3, 2025 |
| Feb 28, 2025 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | +125,833 | $0.00 | $0 | 125,833 | Mar 3, 2025 |
| Jan 15, 2025 | Jonathan H Kaufman See remarks below. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | -303,041 | $0.00 | $0 | 0 | Jan 17, 2025 |
| Jan 15, 2025 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan | -85,421 | $0.00 | $0 | 0 | Jan 17, 2025 |
| Jan 15, 2025 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan | -11,795 | $0.00 | $0 | 0 | Jan 17, 2025 |
| Dec 31, 2024 | Jonathan H Kaufman See remarks below. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | +42,933 | $0.00 | $0 | 303,041 | Jan 3, 2025 |
| Dec 31, 2024 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan | +11,795 | $0.00 | $0 | 11,795 | Jan 3, 2025 |
| Dec 23, 2024 | Jonathan H Kaufman See remarks below. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan (as defined below) | +260,108 | $0.00 | $0 | 260,108 | Dec 27, 2024 |
| Dec 23, 2024 | Jonathan H Kaufman See remarks below. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan | +85,421 | $0.00 | $0 | 85,421 | Dec 27, 2024 |
| May 14, 2024 | Jonathan H Kaufman See remarks below. | POpen-market purchase Common Stock | +10,000 | $0.76 | $7,590 | 898,849 | May 15, 2024 |
| Mar 18, 2024 | Jonathan H Kaufman See remarks below. | POpen-market purchase Common Stock | +30,000 | $0.79 | $24k | 863,849 | Mar 19, 2024 |
| Mar 15, 2024 | Lori Birder director | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Mar 19, 2024 |
| Mar 15, 2024 | Michael B Chancellor Chief Medical Officer | AGrant or award Stock Optionsderivative | +80,000 | $0.00 | $0 | 80,000 | Mar 19, 2024 |
| Mar 15, 2024 | Daniel R Cohen director | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Mar 19, 2024 |
| Mar 15, 2024 | Douglas Johnston Chief Financial Officer | AGrant or award Stock Optionsderivative | +50,000 | $0.00 | $0 | 50,000 | Mar 19, 2024 |
| Mar 15, 2024 | Byong Kim director | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Mar 19, 2024 |
| Mar 15, 2024 | Naoki Yoshimura director | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Mar 19, 2024 |
| Mar 15, 2024 | Ryan Pruchnic director | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Mar 19, 2024 |
| Mar 19, 2024 | Jonathan H Kaufman See remarks below. | POpen-market purchase Common Stock | +25,000 | $0.87 | $22k | 888,849 | Mar 19, 2024 |
| Mar 15, 2024 | Jonathan H Kaufman See remarks below. | AGrant or award Stock Optionsderivative | +80,000 | $0.00 | $0 | 80,000 | Mar 19, 2024 |
| Mar 13, 2024 | Michael B Chancellor Chief Medical Officer | AGrant or award Common Stock | +144,906 | $0.69 | $100k | 877,637 | Mar 15, 2024 |
| Mar 13, 2024 | Jonathan H Kaufman See remarks below. | AGrant or award Common Stock | +144,906 | $0.69 | $100k | 833,849 | Mar 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Lori Birderdirector
- Michael B ChancellorChief Medical Officer
- Daniel R Cohendirector
- Douglas JohnstonChief Financial Officer
- Jonathan H KaufmanSee remarks below.
- Byong Kimdirector
- Ryan Pruchnicdirector
- Naoki Yoshimuradirector
Questions about LIPO
Answered from the filings on this page, as of the latest one.
Are insiders buying LIPO?
No. In the last 90 days no insider at LIPELLA PHARMACEUTICALS INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade LIPO on the open market?
Jonathan H Kaufman (See remarks below.) bought $7,590 of LIPO on May 14, 2024 and filed the Form 4 on May 15, 2024. InsiderTell scored 20 (weak).
How many insiders file Form 4 at LIPELLA PHARMACEUTICALS INC.?
8 people have filed a Form 4 at LIPELLA PHARMACEUTICALS INC., among them Lori Birder (director), Michael B Chancellor (Chief Medical Officer), Daniel R Cohen (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.